688399 硕世生物
已收盘 10-23 15:00:00
资讯
新帖
简况
图解硕世生物三季报：第三季度单季净利润同比增长27.18%
证券之星 · 01:22
图解硕世生物三季报：第三季度单季净利润同比增长27.18%
硕世生物（688399）10月19日主力资金净卖出570.03万元
证券之星 · 10-20
硕世生物（688399）10月19日主力资金净卖出570.03万元
硕世生物（688399）10月14日主力资金净卖出381.33万元
证券之星 · 10-15
硕世生物（688399）10月14日主力资金净卖出381.33万元
股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于控股股东涉及诉讼的公告》
证券之星 · 10-15
股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于控股股东涉及诉讼的公告》
股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司第三届董事会第十八次会议决议公告》
证券之星 · 10-12
股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司第三届董事会第十八次会议决议公告》
硕世生物控制权博弈持续发酵
东方财富网 · 10-10
硕世生物控制权博弈持续发酵
硕世生物换届提案遭否决：控制权拉锯拷问公司治理与经营韧性
新浪证券 · 10-10
硕世生物换届提案遭否决：控制权拉锯拷问公司治理与经营韧性
硕世生物（688399）10月9日主力资金净买入1739.21万元
证券之星 · 10-10
硕世生物（688399）10月9日主力资金净买入1739.21万元
硕世生物最新公告：董事会否决控股股东提请召开临时股东会议案
证券之星 · 10-08
硕世生物最新公告：董事会否决控股股东提请召开临时股东会议案
硕世生物：截至2026年9月30日，公司股东总数10,077户
证券之星 · 10-08
硕世生物：截至2026年9月30日，公司股东总数10,077户
股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于召开2026年半年度业绩说明会的公告》
证券之星 · 09-30
股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于召开2026年半年度业绩说明会的公告》
硕世生物（688399）披露2026年半年度业绩说明会安排，9月28日股价下跌2.35%
证券之星 · 09-28
硕世生物（688399）披露2026年半年度业绩说明会安排，9月28日股价下跌2.35%
股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于收到控股股东提请召开临时股东会的函的公告》
证券之星 · 09-28
股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于收到控股股东提请召开临时股东会的函的公告》
硕世生物控制权纷争升级：控股股东提请召开临时股东会以推动董事会换届，现任董事长未在提名名单中
每日经济新闻 · 09-24
硕世生物控制权纷争升级：控股股东提请召开临时股东会以推动董事会换届，现任董事长未在提名名单中
一致行动人“散伙” 谁在争夺硕世生物控制权？
东方财富网 · 09-24
一致行动人“散伙” 谁在争夺硕世生物控制权？
硕世生物(688399.SH)取得两项医疗器械注册证
智通财经 · 09-24
硕世生物(688399.SH)取得两项医疗器械注册证
硕世生物（688399）9月23日主力资金净买入298.92万元
证券之星 · 09-24
硕世生物（688399）9月23日主力资金净买入298.92万元
股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司简式权益变动报告书》
证券之星 · 09-24
股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司简式权益变动报告书》
股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于合伙企业变更执行事务合伙人暨股东权益变动的提示性公告》
证券之星 · 09-23
股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于合伙企业变更执行事务合伙人暨股东权益变动的提示性公告》
硕世生物（688399）披露董事会延期换届选举公告，9月21日股价上涨5.51%
证券之星 · 09-21
硕世生物（688399）披露董事会延期换届选举公告，9月21日股价上涨5.51%
加载更多
公司概况
公司名称：
江苏硕世生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2019-12-05
主营业务：
江苏硕世生物科技股份有限公司的主营业务是体外诊断试剂、配套检测仪器等体外诊断产品的研发、生产和销售。公司的主要产品是体外诊断试剂、配套检测仪器等体外诊断产品。
发行价格：
46.78
{"stockData":{"symbol":"688399","market":"SH","secType":"STK","nameCN":"硕世生物","latestPrice":23.7,"timestamp":1792738800000,"preClose":23.13,"halted":0,"volume":2350041,"delay":0,"changeRate":0.0246,"floatShares":124000000,"shares":124000000,"eps":-0.2055,"marketStatus":"已收盘","change":0.57,"latestTime":"10-23 15:00:00","open":22.97,"high":23.75,"low":21.62,"amount":53097900,"amplitude":0.0921,"askPrice":23.71,"askSize":200,"bidPrice":23.7,"bidSize":23,"shortable":0,"etf":0,"ttmEps":-0.2055,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792978200000},"marketStatusCode":5,"adr":0,"adjPreClose":23.13,"symbolType":"stock_kcb","openAndCloseTimeList":[[1792719000000,1792726200000],[1792731600000,1792738800000]],"highLimit":25.44,"lowLimit":20.82,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":124130147,"isCdr":false,"pbRate":1,"roa":"--","roe":"0.67%","epsLYR":-0.49,"committee":-0.120536,"marketValue":2942000000,"turnoverRate":0.0189,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-10-26。","afterMarket":{"amount":0,"volume":0,"close":23.7,"buyVolume":0,"sellVolume":700,"time":1792740837746,"indexStatus":"已收盘 10-23 15:30:00","preClose":23.13},"floatMarketCap":2942000000},"requestUrl":"/m/hq/s/688399","defaultTab":"news","newsList":[{"id":"2677971820","title":"图解硕世生物三季报：第三季度单季净利润同比增长27.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677971820","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677971820?lang=zh_cn&edition=full","pubTime":"2026-10-24 01:22","pubTimestamp":1792776128,"startTime":"0","endTime":"0","summary":"证券之星消息，硕世生物2026年三季报显示，前三季度公司主营收入2.29亿元，同比下降11.11%；归母净利润1895.22万元，同比上升501.34%；扣非净利润-2797.5万元，同比上升32.42%；其中2026年第三季度，公司单季度主营收入8146.24万元，同比下降0.57%；单季度归母净利润-61.23万元，同比上升27.18%；单季度扣非净利润-880.72万元，同比上升34.0%；负债率19.76%，投资收益849.21万元，财务费用685.95万元，毛利率62.9%。财报数据概要请见下图:本文数据来源于硕世生物2026年三季报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102400002281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676637621","title":"硕世生物（688399）10月19日主力资金净卖出570.03万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676637621","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676637621?lang=zh_cn&edition=full","pubTime":"2026-10-20 08:31","pubTimestamp":1792456286,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月19日收盘，硕世生物报收于23.39元，下跌3.15%，换手率1.93%，成交量2.4万手，成交额5619.27万元。近5日资金流向一览见下表：硕世生物融资融券信息显示，融资方面，当日融资买入830.64万元，融资偿还1122.07万元，融资净偿还291.42万元。硕世生物主营业务：公司专注于体外诊断试剂、配套检测仪器等体外诊断产品的研发、生产和销售,并拓展到体外检测服务领域,实现“试剂+仪器+服务”的一体化经营模式。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000005361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675375200","title":"硕世生物（688399）10月14日主力资金净卖出381.33万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675375200","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675375200?lang=zh_cn&edition=full","pubTime":"2026-10-15 08:31","pubTimestamp":1792024284,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月14日收盘，硕世生物报收于25.14元，下跌4.56%，换手率2.0%，成交量2.48万手，成交额6368.83万元。近5日资金流向一览见下表：硕世生物融资融券信息显示，融资方面，当日融资买入580.37万元，融资偿还780.24万元，融资净偿还199.87万元。硕世生物主营业务：公司专注于体外诊断试剂、配套检测仪器等体外诊断产品的研发、生产和销售,并拓展到体外检测服务领域,实现“试剂+仪器+服务”的一体化经营模式。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500007165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675321580","title":"股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于控股股东涉及诉讼的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675321580","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675321580?lang=zh_cn&edition=full","pubTime":"2026-10-15 02:17","pubTimestamp":1792001828,"startTime":"0","endTime":"0","summary":"公司公告汇总江苏硕世生物科技股份有限公司关于控股股东涉及诉讼的公告江苏硕世生物科技股份有限公司公告，其控股股东绍兴闰康生物医药股权投资合伙企业因退伙纠纷，向上海市普陀区人民法院提起诉讼，请求确认有限合伙人梁锡林于2026年9月30日退伙，并协助办理工商变更登记。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500001811.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674084303","title":"股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司第三届董事会第十八次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674084303","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674084303?lang=zh_cn&edition=full","pubTime":"2026-10-12 01:35","pubTimestamp":1791740109,"startTime":"0","endTime":"0","summary":"公司公告汇总江苏硕世生物科技股份有限公司第三届董事会第十八次会议决议公告江苏硕世生物科技股份有限公司第三届董事会第十八次会议于2026年10月2日以通讯方式召开，审议《关于同意控股股东提请召开临时股东会的议案》。反对董事认为控股股东闰康生物印章效力存在争议，且其解散之诉正在审理中，相关事项可能影响公司控制权稳定。律师事务所认为本次董事会召集、召开程序合法，决议有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200000504.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674765897","title":"硕世生物控制权博弈持续发酵","url":"https://stock-news.laohu8.com/highlight/detail?id=2674765897","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674765897?lang=zh_cn&edition=full","pubTime":"2026-10-10 21:32","pubTimestamp":1791639165,"startTime":"0","endTime":"0","summary":"一场本应按流程推进的董事会换届，最终演变成控股股东与在任董事会之间的公开对峙。10月8日，科创板体外诊断企业硕世生物（688399.SH）披露第三届董事会第十八次会议决议公告，控股股东闰康生物提请召开临时股东会审议换届选举的议案，最终以4票同意、5票反对的微弱差距未获通过。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://finance.eastmoney.com/news/1354,202610103891996465.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1354,202610103891996465.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674289660","title":"硕世生物换届提案遭否决：控制权拉锯拷问公司治理与经营韧性","url":"https://stock-news.laohu8.com/highlight/detail?id=2674289660","media":"新浪证券","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674289660?lang=zh_cn&edition=full","pubTime":"2026-10-10 14:38","pubTimestamp":1791614280,"startTime":"0","endTime":"0","summary":"10 月 8 日，科创板 IVD 企业硕世生物披露董事会决议，控股股东闰康生物提请召开临时股东大会开展董事会换届的议案，以 4 票同意、5 票反对未获通过。梁锡林已经提起解散闰康生物的诉讼，同时就资金挪用问题报案并取得受案回执。本次董事会 5 张反对票直指核心风险：闰康生物提请文件印章备案信息存疑，提案能否代表控股股东真实意思存疑；在解散诉讼、资金纠纷尚未尘埃落定的背景下仓促换届，将损害中小投资者利益。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-10-10/doc-iniutkcp7455146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688399","SYLD","WCEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674867732","title":"硕世生物（688399）10月9日主力资金净买入1739.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674867732","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674867732?lang=zh_cn&edition=full","pubTime":"2026-10-10 08:12","pubTimestamp":1791591131,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月9日收盘，硕世生物报收于29.92元，上涨9.92%，换手率6.49%，成交量8.05万手，成交额2.37亿元。近5日资金流向一览见下表：硕世生物融资融券信息显示，融资方面，当日融资买入3386.98万元，融资偿还1926.14万元，融资净买入1460.84万元。硕世生物主营业务：公司专注于体外诊断试剂、配套检测仪器等体外诊断产品的研发、生产和销售,并拓展到体外检测服务领域,实现“试剂+仪器+服务”的一体化经营模式。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101000003754.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673055170","title":"硕世生物最新公告：董事会否决控股股东提请召开临时股东会议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2673055170","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673055170?lang=zh_cn&edition=full","pubTime":"2026-10-08 22:40","pubTimestamp":1791470435,"startTime":"0","endTime":"0","summary":"硕世生物(688399.SH)公告称，公司第三届董事会第十八次会议审议《关于同意控股股东提请召开临时股东会的议案》，表决结果为4票同意、5票反对，议案未获通过。董事会不同意召开临时股东会。5名反对董事认为，控股股东闰康生物相关文件印章效力存在争议，且其解散之诉正在审理中，有限合伙人梁锡林已就资金被挪用事宜向公安机关报案并获受理，现阶段推进换届不利于公司治理稳定及中小投资者利益保护。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800034770.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673759210","title":"硕世生物：截至2026年9月30日，公司股东总数10,077户","url":"https://stock-news.laohu8.com/highlight/detail?id=2673759210","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673759210?lang=zh_cn&edition=full","pubTime":"2026-10-08 18:09","pubTimestamp":1791454144,"startTime":"0","endTime":"0","summary":"证券之星消息，硕世生物(688399)10月08日在投资者关系平台上答复投资者关心的问题。投资者提问：您好！请问截至9月30日公司股东人数是多少，谢谢硕世生物回复：尊敬的投资者您好，根据中登公司最新下发的股东名册，截至2026年9月30日，公司股东总数10,077户。感谢您的关注!本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800024782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671414562","title":"股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于召开2026年半年度业绩说明会的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2671414562","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671414562?lang=zh_cn&edition=full","pubTime":"2026-09-30 02:16","pubTimestamp":1790705770,"startTime":"0","endTime":"0","summary":"截至2026年9月29日收盘，硕世生物报收于26.78元，下跌0.74%，换手率1.06%，成交量1.32万手，成交额3553.04万元。当日关注点交易信息汇总：9月29日主力资金净流出233.1万元，占总成交额6.56%。公司公告汇总：硕世生物将于2026年10月14日16:00-17:00召开2026年半年度业绩说明会，通过上证路演中心网络互动方式举行。投资者可于2026年9月30日至10月13日16:00前通过上证路演中心网站或公司邮箱sssw@s-sbio.com提问。说明会结束后可通过上证路演中心查看会议情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000002487.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670556862","title":"硕世生物（688399）披露2026年半年度业绩说明会安排，9月28日股价下跌2.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670556862","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670556862?lang=zh_cn&edition=full","pubTime":"2026-09-28 22:30","pubTimestamp":1790605839,"startTime":"0","endTime":"0","summary":"截至2026年9月28日收盘，硕世生物报收于26.98元，较前一交易日下跌2.35%，最新总市值为33.49亿元。该股当日开盘27.51元，最高28.01元，最低26.71元，成交额达4553.41万元，换手率为1.35%。公告显示，公司将于2026年10月14日16:00-17:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会，介绍公司2026年半年度经营成果及财务状况。投资者可于2026年9月30日至10月13日16:00前通过上证路演中心网站或公司邮箱sssw@s-sbio.com提问。说明会结束后可通过上证路演中心查看会议情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800035194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670340906","title":"股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于收到控股股东提请召开临时股东会的函的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2670340906","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670340906?lang=zh_cn&edition=full","pubTime":"2026-09-28 02:37","pubTimestamp":1790534230,"startTime":"0","endTime":"0","summary":"公司董事会将对提请函进行核查及审议，并在规定时间内作出是否召开临时股东会的书面反馈。江苏硕世生物科技股份有限公司关于自愿披露取得医疗器械注册证的公告江苏硕世生物科技股份有限公司近日收到国家药品监督管理局签发的两项医疗器械注册证，分别为丙型肝炎病毒核酸检测试剂盒和基孔肯雅病毒核酸检测试剂盒，注册分类均为三类，有效期均至2031年9月23日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800001320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669499372","title":"硕世生物控制权纷争升级：控股股东提请召开临时股东会以推动董事会换届，现任董事长未在提名名单中","url":"https://stock-news.laohu8.com/highlight/detail?id=2669499372","media":"每日经济新闻","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669499372?lang=zh_cn&edition=full","pubTime":"2026-09-24 22:11","pubTimestamp":1790259060,"startTime":"0","endTime":"0","summary":"值得注意的是，在闰康生物提名的8位候选人中，硕世生物现任董事长王国强、董事梁钶承未在提名名单中。此次闰康生物提请的直接理由是董事会任期届满，董事会组成人员已被动超期任职。硕世生物控股股东、实控人存在发生变更风险控股股东闰康生物此次主动出击，或与房永生表决权刚刚被削弱有关。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-24/doc-inisxxkt8176396.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-24/doc-inisxxkt8176396.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669496886","title":"一致行动人“散伙” 谁在争夺硕世生物控制权？","url":"https://stock-news.laohu8.com/highlight/detail?id=2669496886","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669496886?lang=zh_cn&edition=full","pubTime":"2026-09-24 21:50","pubTimestamp":1790257800,"startTime":"0","endTime":"0","summary":"硕世生物正面临控制权结构动荡的局面。近日，公司发布公告称，股东泰州硕康企业管理咨询合伙企业（有限合伙）（简称“泰州硕康”）、泰州硕源企业管理咨询合伙企业（有限合伙）（简称“泰州硕源”）完成工商变更，执行事务合伙人由公司实际控制人房永生变更为梁钶承。变更完成后，房永生不再控制泰州硕康、泰州硕源。房永生合计控制硕世生物股份比例从32.24%下降为28.43%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://finance.eastmoney.com/news/1354,202609243883915638.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1354,202609243883915638.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669838466","title":"硕世生物(688399.SH)取得两项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2669838466","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669838466?lang=zh_cn&edition=full","pubTime":"2026-09-24 17:17","pubTimestamp":1790241437,"startTime":"0","endTime":"0","summary":"智通财经APP讯，硕世生物(688399.SH)发布公告，公司近日收到国家药品监督管理局签发的医疗器械注册证(体外诊断试剂)，产品名称：丙型肝炎病毒核酸检测试剂盒(荧光PCR法)、基孔肯雅病毒核酸检测试剂盒(荧光PCR法)。上述《医疗器械注册证》的取得，丰富了公司产品种类，扩充了公司在体外诊断领域的布局，不断满足多元化的临床需求，将增强公司综合竞争力，有利于进一步提高公司的市场拓展能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1500500.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AGNG","IEIH","MDEV","688399","LGHT","LNGR","BK1574","GDOC","RSPH","BK1100","BK1583","BK0239","159883","09996","MEDX","PTH","HART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669432089","title":"硕世生物（688399）9月23日主力资金净买入298.92万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669432089","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669432089?lang=zh_cn&edition=full","pubTime":"2026-09-24 08:23","pubTimestamp":1790209432,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月23日收盘，硕世生物报收于27.89元，上涨2.16%，换手率2.04%，成交量2.53万手，成交额7022.37万元。近5日资金流向一览见下表：硕世生物融资融券信息显示，融资方面，当日融资买入418.47万元，融资偿还450.75万元，融资净偿还32.28万元。硕世生物主营业务：公司专注于体外诊断试剂、配套检测仪器等体外诊断产品的研发、生产和销售,并拓展到体外检测服务领域,实现“试剂+仪器+服务”的一体化经营模式。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400007817.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669433620","title":"股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司简式权益变动报告书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669433620","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669433620?lang=zh_cn&edition=full","pubTime":"2026-09-24 02:16","pubTimestamp":1790187372,"startTime":"0","endTime":"0","summary":"公司公告汇总江苏硕世生物科技股份有限公司简式权益变动报告书江苏硕世生物科技股份有限公司发布简式权益变动报告书，因股东泰州硕康、泰州硕源完成工商变更，执行事务合伙人由实际控制人房永生变更为梁钶承，导致房永生不再控制该两家企业，一致行动关系解除，其支配的公司股份表决权比例由32.24%下降至28.43%。信息披露义务人未来12个月内不排除增减持计划。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400002368.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669129753","title":"股市必读：硕世生物新发布《江苏硕世生物科技股份有限公司关于合伙企业变更执行事务合伙人暨股东权益变动的提示性公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669129753","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669129753?lang=zh_cn&edition=full","pubTime":"2026-09-23 02:02","pubTimestamp":1790100135,"startTime":"0","endTime":"0","summary":"公司公告汇总江苏硕世生物科技股份有限公司关于合伙企业变更执行事务合伙人暨股东权益变动的提示性公告江苏硕世生物科技股份有限公司股东泰州硕康、泰州硕源完成工商变更，执行事务合伙人由房永生变更为梁钶承。房永生已对变更提出异议，若诉讼成功，控制权可能恢复。此外，控股股东闰康生物涉诉，存在被解散风险，可能导致公司控制权变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300002441.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669549001","title":"硕世生物（688399）披露董事会延期换届选举公告，9月21日股价上涨5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669549001","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669549001?lang=zh_cn&edition=full","pubTime":"2026-09-21 17:36","pubTimestamp":1789983384,"startTime":"0","endTime":"0","summary":"截至2026年9月21日收盘，硕世生物报收于26.61元，较前一交易日上涨5.51%，最新总市值为33.03亿元。江苏硕世生物科技股份有限公司于近日发布《关于公司董事会延期换届选举的提示性公告》。公告显示，公司第三届董事会于2026年9月19日届满，因换届准备工作尚未完成，董事会换届选举将延期，董事会各专门委员会及高级管理人员任期相应顺延。公司预计延期换届不会对正常经营产生重大影响，并将及时披露后续进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100022415.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792814559555,"stockEarnings":[{"period":"1week","weight":-0.0186},{"period":"1month","weight":-0.1502},{"period":"3month","weight":-0.0978},{"period":"6month","weight":-0.4247},{"period":"1year","weight":-0.5347},{"period":"ytd","weight":-0.4879}],"compareEarnings":[{"period":"1week","weight":-0.0069},{"period":"1month","weight":-0.0625},{"period":"3month","weight":-0.0324},{"period":"6month","weight":-0.0954},{"period":"1year","weight":-0.0591},{"period":"ytd","weight":-0.0701}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏硕世生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"10077人(较上一季度增加7.67%)","perCapita":"12318股","listingDate":"2019-12-05","address":"江苏省泰州市海陵区药城大道837号","registeredCapital":"12413万元","survey":" 江苏硕世生物科技股份有限公司的主营业务是体外诊断试剂、配套检测仪器等体外诊断产品的研发、生产和销售。公司的主要产品是体外诊断试剂、配套检测仪器等体外诊断产品。","listedPrice":46.78},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"硕世生物(688399)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供硕世生物(688399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"硕世生物,688399,硕世生物股票,硕世生物股票老虎,硕世生物股票老虎国际,硕世生物行情,硕世生物股票行情,硕世生物股价,硕世生物股市,硕世生物股票价格,硕世生物股票交易,硕世生物股票购买,硕世生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"硕世生物(688399)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供硕世生物(688399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}